IP Library Granted Patent US 9,988,656
Granted Patent B2
US 9,988,656 · App. 14/954,487 · Granted Jun 5, 2018

Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,656
App. No.
14/954,487
Granted
Jun 5, 2018
Kind
B2
Abstract

The invention provides non-naturally occurring microbial organisms comprising 1,4-butanediol (14-BDO) and gamma-butyrolactone (GBL) pathways comprising at least one exogenous nucleic acid encoding a 14-BDO and GBL pathway enzyme expressed in a sufficient amount to produce 14-BDO and GBL. The invention additionally provides methods of using such microbial organisms to produce 14-BDO and GBL.

Claims (14)

1. A non-naturally occurring microbial organism comprising exogenous nucleic acids encoding a combination of enzymes of:

a 4-hydroxybutyrate dehydrogenase; a 4-hydroxybutyryl-CoA transferase; a 4-hydroxybutyryl-CoA reductase (aldehyde forming); a 1,4-butanediol dehydrogenase; and a 4-hydroxybutyrate lactonase;

wherein the exogenous nucleic acids are expressed in the microbial organism.

2. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism further comprises exogenous nucleic acids encoding a second combination of enzymes selective from the group consisting of:

(a) a succinyl-CoA transferase, a succinyl-CoA hydrolase, or a succinyl-CoA synthetase; and a succinyl-CoA reductase (aldehyde forming);

(b) an alpha-ketoglutarate decarboxylase; and

(c) a glutamate dehydrogenase or glutamate transaminase; a glutamate decarboxylase; and a 4-aminobutyrate dehydrogenase or a 4-aminobutyrate transaminase,

wherein the exogenous nucleic acids encoding the second combination of enzymes are expressed in the microbial organism.

3. The non-naturally occurring microbial organism of claim 1 , wherein at least one, two, three, four or five of the exogenous nucleic acids is a heterologous encoding nucleic acid.

4. The non-naturally occurring microbial organism of claim 1 , wherein the exogenous nucleic acids are heterologous encoding nucleic acids.

5. The non-naturally occurring microbial organism of claim 1 , wherein the microbial organism is a bacterium, yeast or fungus.

6. The non-naturally occurring microbial organism of claim 5 , wherein the bacterium is selected from the group consisting of Escherichia coli, Klebsiella oxytoca, Anaerobiospirillum succiniciproducens, Actinobacillus succinogenes, Mannheimia succiniciproducens, Rhizobium etli, Bacillus subtilis, Corynebacterium glutamicum, Gluconobacter oxydans, Zymomonas mobilis, Lactococcus lactis, Lactobacillus plantarum, Streptomyces coelicolor, Clostridium acetobutylicum, Pseudomonas fluorescens , and Pseudomonas putida.

7. The non-naturally occurring microbial organism of claim 5 , wherein the yeast or fungus is selected from the group consisting of Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces marxianus, Aspergillus terreus, Aspergillus niger, Pichia pastoris, Rhizopus arrhizus , and Rhizobus oryzae.

8. A composition comprising the non-naturally occurring microbial organism of claim 1 in a substantially anaerobic culture medium.

Assignments (3)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →